Nurrohman A, Suwito H, Puspaningsih N, Haq K
RSC Adv. 2024; 14(52):39017-39026.
PMID: 39659606
PMC: 11629752.
DOI: 10.1039/d4ra07713j.
Xu J, Luo Q, Huang Y, Li J, Ye W, Yan R
Emerg Microbes Infect. 2024; 13(1):2429627.
PMID: 39530458
PMC: 11600549.
DOI: 10.1080/22221751.2024.2429627.
Duwe S, Milde J, Heider A, Wedde M, Schweiger B, Durrwald R
Viruses. 2024; 16(7).
PMID: 39066271
PMC: 11281601.
DOI: 10.3390/v16071109.
Yates P, Mehta N, Watson H, Peppercorn A
Virus Res. 2023; 325:199039.
PMID: 36610656
PMC: 10194138.
DOI: 10.1016/j.virusres.2023.199039.
Qin J, Lin J, Zhang X, Yuan S, Zhang C, Yin Y
Front Pharmacol. 2022; 13:849545.
PMID: 35462914
PMC: 9020783.
DOI: 10.3389/fphar.2022.849545.
Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance.
Bai Y, Jones J, Wong S, Zanin M
Viruses. 2021; 13(4).
PMID: 33917376
PMC: 8067422.
DOI: 10.3390/v13040624.
In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients.
Takashita E, Fujisaki S, Yokoyama M, Shirakura M, Morita H, Nakamura K
Pathogens. 2020; 9(9).
PMID: 32887429
PMC: 7559125.
DOI: 10.3390/pathogens9090725.
Antivirals Targeting the Neuraminidase.
Gubareva L, Mohan T
Cold Spring Harb Perspect Med. 2020; 12(1).
PMID: 32152244
PMC: 8725622.
DOI: 10.1101/cshperspect.a038455.
Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.
Treurnicht F, Buys A, Tempia S, Seleka M, Cohen A, Walaza S
Influenza Other Respir Viruses. 2018; 13(1):54-63.
PMID: 30218485
PMC: 6304311.
DOI: 10.1111/irv.12611.
An easy, rapid, and sensitive method for detection of drug-resistant influenza virus by using a sialidase fluorescent imaging probe, BTP3-Neu5Ac.
Kato D, Kurebayashi Y, Takahashi T, Otsubo T, Otake H, Yamazaki M
PLoS One. 2018; 13(7):e0200761.
PMID: 30001430
PMC: 6042793.
DOI: 10.1371/journal.pone.0200761.
Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.
Hsu K, Hung H, HuangFu W, Sung T, Lin T, Fang M
Sci Rep. 2017; 7(1):12336.
PMID: 28951584
PMC: 5615050.
DOI: 10.1038/s41598-017-12101-3.
Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance.
Han J, Perez J, Schafer A, Cheng H, Peet N, Rong L
Curr Med Chem. 2017; 25(38):5115-5127.
PMID: 28933281
PMC: 8735713.
DOI: 10.2174/0929867324666170920165926.
A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir.
Abed Y, Boivin G
Open Forum Infect Dis. 2017; 4(3):ofx105.
PMID: 28852674
PMC: 5569976.
DOI: 10.1093/ofid/ofx105.
Drug resistance in influenza A virus: the epidemiology and management.
Hussain M, Galvin H, Haw T, Nutsford A, Husain M
Infect Drug Resist. 2017; 10:121-134.
PMID: 28458567
PMC: 5404498.
DOI: 10.2147/IDR.S105473.
Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.
Wu Y, Gao F, Qi J, Bi Y, Fu L, Mohan S
J Virol. 2016; 90(23):10693-10700.
PMID: 27654293
PMC: 5110174.
DOI: 10.1128/JVI.01703-16.
Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance.
Wee K, Lee R, Lin J, Pramono Z, Maurer-Stroh S
PLoS Comput Biol. 2016; 12(1):e1004663.
PMID: 26771381
PMC: 4714944.
DOI: 10.1371/journal.pcbi.1004663.
Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.
Song M, Marathe B, Kumar G, Wong S, Rubrum A, Zanin M
J Virol. 2015; 89(21):10891-900.
PMID: 26292325
PMC: 4621141.
DOI: 10.1128/JVI.01514-15.
E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
LHuillier A, Abed Y, Petty T, Cordey S, Thomas Y, Bouhy X
J Infect Dis. 2015; 212(11):1726-34.
PMID: 25985905
PMC: 4633758.
DOI: 10.1093/infdis/jiv288.
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.
Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T
Antiviral Res. 2015; 117:27-38.
PMID: 25721488
PMC: 9036627.
DOI: 10.1016/j.antiviral.2015.02.003.
Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
Baek Y, Song M, Lee E, Kim Y, Kim E, Park S
J Virol. 2014; 89(1):287-99.
PMID: 25320319
PMC: 4301112.
DOI: 10.1128/JVI.02485-14.
